Medpace Holdings Inc

Healthcare · Diagnostics & Research

602.90$ -2.8% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Income Statement

Medpace Holdings Inc (MEDP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 707 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement MEDP
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	108	108	107	106	111	113	163	170	179	192	201	214	216	230	231	205	230	260	260	278	296	309	331	351	384	394	434	461	492	498	511	528	533	537	559	603	660	708	707	707	2,782
Cost of Revenue	64	64	64	64	65	69	117	117	124	131	146	150	152	167	166	148	156	177	182	204	208	221	232	252	265	278	304	337	359	362	356	374	364	358	380	423	463	503	510	506	1,982
Gross Profit	44	44	43	43	46	44	46	53	55	61	55	64	64	63	65	57	74	83	78	75	87	88	99	99	119	116	130	124	133	137	155	154	169	178	178	180	197	205	196	202	800
Research & Development	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Selling, General & Administrative	16	17	15	15	17	17	16	21	19	21	21	24	29	21	25	22	23	25	26	27	28	26	29	33	35	32	38	39	41	41	44	41	49	44	58	47	48	45	48	48	189
Total Operating Expenses	31	31	27	26	28	28	26	30	28	30	29	29	34	27	30	27	28	28	31	32	33	33	34	39	41	39	44	46	48	49	51	49	57	53	65	54	55	52	55	55	217
Operating Income	13	13	16	16	17	15	20	23	27	31	26	35	30	36	36	30	46	55	48	42	54	55	64	60	78	76	86	78	85	87	104	105	112	125	114	126	142	153	142	147	583
Interest Expense	4.7	2.8	1.8	1.8	1.9	2.1	2.3	2.3	1.9	1.6	1.0	0.7	0.3	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.6	0.8	0.9	1.4	0.1	1.8	4.1	5.5	7.5	7.9	–	–	–	–	–	–	–
Pre-Tax Income	7.6	0.2	14	14	15	14	18	22	25	29	25	34	29	36	36	30	47	55	49	43	55	56	65	62	82	74	86	76	83	91	113	110	119	134	118	125	143	157	148	152	599
Income Tax Expense	2.5	0.2	5.3	4.8	5.3	2.4	3.1	4.9	6.2	6.6	5.5	7.0	5.5	6.4	7.5	6.3	5.5	3.8	5.2	2.8	6.2	5.9	4.0	13	16	5.0	13	15	13	12	10	22	22	17	3.6	34	32	22	24	30	107
Net Income	5.0	0.0	8.4	9.6	9.8	11	15	17	19	23	19	27	24	30	29	24	41	51	43	40	49	50	61	49	66	69	73	61	71	78	103	88	96	117	115	90	111	135	124	121	492
EBITDA	27	18	27	28	29	27	30	33	37	41	34	40	35	41	40	35	51	60	53	48	60	61	70	68	89	73	93	84	90	96	120	118	126	141	125	132	150	164	154	134	602

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings